Arvinas (ARVN) Net Margin Growth (3y) (2020 - 2026)
Arvinas (ARVN) Net Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn | 9,283.00 |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - | - |
| 10 | Arvinas | 531.52 Mn | -83.38 Mn | - | -12,062.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,062.00 |
| Dec 31, 2025 | -49,757.00 |
| Sep 30, 2025 | 10,689.00 |
| Jun 30, 2025 | -7,351.00 |
| Mar 31, 2025 | 27,447.00 |
| Dec 31, 2024 | 6,267.00 |
| Sep 30, 2024 | 45,518.00 |
| Jun 30, 2024 | 86,853.00 |
| Mar 31, 2024 | 47,115.00 |
| Dec 31, 2023 | 98,572.00 |
| Sep 30, 2023 | 25,474.00 |
| Jun 30, 2023 | 37,089.00 |
| Mar 31, 2023 | 12,340.00 |
| Dec 31, 2022 | 21,823.00 |
| Sep 30, 2022 | -13,184.00 |
| Jun 30, 2022 | 22,765.00 |
| Mar 31, 2022 | 12,807.00 |
| Dec 31, 2021 | 32,879.00 |
| Sep 30, 2021 | 321,317.00 |
| Jun 30, 2021 | -24,721.00 |